Keyword: BioNTech

News

CureVac Sues BioNTech for IP Infringement

07.07.2022 -

Germany’s BioNTech is pushing back against allegations by compatriot CureVac that the company infringed its intellectual property in formulating its mRNA-based Covid-19...

Research & Innovation

New Covid Shots Score Points against Omicron

27.06.2022 -

Sanofi and GSK are touting their latecomer protein-based Covid-19 vaccine as a potential game changer in the fight against the Omicron variant.

News

FDA Panel Recommends Approval of Nuaxovid

09.06.2022 -

In a vote of 21 in favor with one abstention, the US Food and Drug Administration’s advisory panel has recommended that the FDA approve Novavax’s Covid-19 vaccine...

News

FDA Panel to Review Pediatric mRNA Covid Vaccines

24.05.2022 -

Somewhat later than expected, the US may soon be able to offer Covid-19 vaccinations for children five years of age and younger, something parents have repeatedly...

News

FDA Restricts Use of J&J Covid Vaccine

13.05.2022 -

US health authorities are restricting the use of the Johnson & Johnson Covid vaccine somewhat belatedly, citing the rare blood clotting issues that have dogged this...

News

New Moderna Covid Shot may Trigger Stronger Response

26.04.2022 -

An updated version of Moderna’s Covid-19 vaccine is claimed to produce a stronger immune response against major variants of the coronavirus, including omicron and delta...

News

Six Firms to Make Vaccines for German Emergency Supply

12.04.2022 -

Germany’s economics ministry has budgeted up to €2.9 billion ($3.14 billion) to ensure sufficient supply of mostly mRNA-based Covid-19 vaccines to be able to deal with...

News

FDA Panel Meeting to Discuss Covid Vaccine Boosters

22.03.2022 -

The US Food and Drug Administration has scheduled a virtual meeting of its scientific advisory panel for Apr. 6 to discuss the prospect of future Covid-19 boosters and...